Evaluation of pharmaceutically compounded oral caffeine on the impact of medication adherence and risk of readmission among preterm neonates: A single-center quasi-experimental study

BACKGROUND: Caffeine is available in an ampoule, used via parenteral and enteral routes in preterm neonates to treat apnea of prematurity (AOP) in neonates of gestational age ≥ 35–40 weeks. A longer duration of therapy has a higher risk of medication non-adherence due to higher costs and inappropria...

Descripción completa

Detalles Bibliográficos
Autores principales: Ambreen, Gul, Kumar, Manoj, Ali, Amin, Shah, Syed Akbar Ali, Saleem, Syed Muzafar, Tahir, Ayesha, Salat, Muhammad Sohail, Aslam, Muhammad Shahzad, Hussain, Kashif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645656/
https://www.ncbi.nlm.nih.gov/pubmed/36350877
http://dx.doi.org/10.1371/journal.pone.0275655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645656/
https://www.ncbi.nlm.nih.gov/pubmed/36350877
http://dx.doi.org/10.1371/journal.pone.0275655

Ejemplares similares